Skip to main content
. Author manuscript; available in PMC: 2021 Aug 18.
Published in final edited form as: JAMA Ophthalmol. 2016 Sep 1;134(9):1041–1047. doi: 10.1001/jamaophthalmol.2016.2383

Figure 3.

Figure 3.

Five-Year Rates of Age-Related Macular Degeneration (AMD) Progression in Persons Free of Late AMD at Baseline for the Age-Related Eye Disease Study (AREDS) and AREDS2

Five-year progression rates to stages 7 to 9 and to late AMD and 5-year progression rates to neovascular (NV) AMD only and to central geographic atrophy (GA) only are shown. The numbers above each bar are the numbers at risk in that category.